Effect of Inhaled β2-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease.
The fractional exhaled nitric oxide measured at an expiratory flow of 50mL/s (FENO50) is a marker of airway inflammation, and high levels are associated with greater response to steroid treatment. In asthma, FENO50 increases with bronchodilation and decreases with bronchoconstriction, the latter pot...
Main Authors: | Mostafa Amer, Jan Cowan, Andrew Gray, Ben Brockway, Jack Dummer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4892672?pdf=render |
Similar Items
-
Bronchial hyper-responsiveness and exhaled nitric oxide in chronic obstructive pulmonary disease
by: Swiss Medical Weekly
Published: (2007-07-01) -
Exhaled Nitric Oxide and Pulmonary Oxygen Toxicity Susceptibility
by: David M. Fothergill, et al.
Published: (2023-08-01) -
Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study.
by: Wilson, E, et al.
Published: (2014) -
Value of Fractional Exhaled Nitric Oxide in Diagnosing Mild Asthma Responsive to Inhaled Corticosteroids
by: Natasa Karamarkovic Lazarusic, et al.
Published: (2023-05-01) -
Exhaled nitric oxide in pulmonary diseases: a comprehensive review.
by: Barnes, P, et al.
Published: (2010)